Immunomodulatory Properties of Withania somnifera : Regulation of Innate Immune Cells and Clinical Implications
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70427 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Rana Yukta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India. Hauptthemen laut MEDLINE: Withania, Immunity, Innate, Plant Extracts, Immunologic Factors. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CCRAS, Science and Engineering Research Board, Ministry of Ayush, Government of India.
Abstract (Originalsprache)
Withania somnifera (L.) Dunal (WS), commonly known as Ashwagandha , is a prominent medicinal herb in Ayurveda, with extensive therapeutic potential attributed to its diverse phytochemical profile. This review critically examines the immunomodulatory properties of WS, focusing on innate immune cell populations, including neutrophils, eosinophils, macrophages, dendritic cells, and natural killer (NK) cells. Bioactive constituents, particularly withanolides and withaferin A derived mainly from roots and leaves, orchestrate immune responses through modulation of cytokine networks, enhancement of phagocytic activity, and attenuation of oxidative stress. WS constituents regulate key signaling pathways, including ERK, NF‐κB, and JAK/STAT, at transcriptional and translational levels. WS exhibits a dual immunoregulatory role by enhancing innate immune cell functionality while suppressing pathological inflammation in allergic and chronic inflammatory disorders. However, critical gaps persist in elucidating its molecular mechanisms, establishing phytochemical standardization, and defining context‐specific dosing regimens. Collectively, current evidence positions WS as a promising candidate for the management of autoimmune, infectious, and inflammatory diseases. However, it further highlights the need for rigorous mechanistic studies and well‐designed clinical trials to enable its integration into evidence‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
- Central Council for Research in Ayurvedic Sciences, Ministry of Ayush, New Delhi, India.
- Regional Ayurveda Research Institute, Lucknow, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
ORCID-Profile: Sachin Kumar, Madhu Dikshit
Förderung
- CCRAS
- Science and Engineering Research Board
- Ministry of Ayush, Government of India
- Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India
Zitieren
APA
Yukta, R., Gupta, S., Kaur, G., Mondal, P. S., Das, M., Ranade, A., Srivastava, A. K., Kumar, S., Barthwal, M. K., & Dikshit, M. (2026). Immunomodulatory Properties of Withania somnifera : Regulation of Innate Immune Cells and Clinical Implications. Phytotherapy Research. https://doi.org/10.1002/ptr.70427
Vancouver
Yukta R, Gupta S, Kaur G, Mondal PS, Das M, Ranade A, et al. Immunomodulatory Properties of Withania somnifera : Regulation of Innate Immune Cells and Clinical Implications. Phytotherapy Research. 2026. doi:10.1002/ptr.70427
BibTeX
@article{Yukta2026,
author = {Yukta, Rana and Gupta, Sonalika and Kaur, Gagandeep and Mondal, Partha Sarathi and Das, Milirani and Ranade, Anagha and Srivastava, Alok Kumar and Kumar, Sachin and Barthwal, Manoj Kumar and Dikshit, Madhu},
title = {Immunomodulatory Properties of Withania somnifera : Regulation of Innate Immune Cells and Clinical Implications},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70427}
}
EUVIMED